A. I. Kramarenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. I. Kramarenko has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Konstantin Popugaev
ФГБУ «Национальный медицинский исследовательский центр хирургии имени А. В. Вишневского» Минздрава России
3 shared publications - Elena Valerievna Klychnikova
N.V. Sklifosovsky Research Institute for Emergency Medicine; N.I. Pirogov Russian National Research Medical University
2 shared publications - Elizaveta Vladimirova
N.V. Sklifosovsky Research Institute of Emergency Medicine
2 shared publications - I. E. Popova
N.V. Sklifosovsky Research Institute of Emergency Medicine
2 shared publications - Leonid S. Kokov
N. V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Department of Health
2 shared publications - M. V. Parkhomenko
НИИ Скорой помощи им. Н.В. Склифосовского ДЗМ
2 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 18 (2) , 205-214
The first experience of two-stage transcatheter implantation of bioprostheses in mitral and tricuspid valve (Valve-in-Valve) prostheses in a high-risk surgical patient
Introduction. Structural degeneration of biological prosthetic heart valves is an inevitable complication in the long term, requiring repeated surgery. Repeated open surgery is associated with a high risk in comorbid patients. Valve-in-Valve (ViV) transcatheter technology has become a minimally invasive alternative. Objective. To demonstrate the effectiveness and safety of a two-stage ViV strategy on tricuspid and mitral valves. Material and methods. A clinical case of a patient born in 1947 with mitral valve (MC) and tricuspid valve (TC) bioprostheses 7 years after the initial open prosthetics is presented. The calculated risk of EuroSCORE II was 21.8%. A two-stage strategy was applied: on 09.29.2025, transcatheter implantation of the MyVal 30.5 mm bioprosthesis was performed in the tricuspid valve position, and on 10.10.2025, MyVal 27.5 mm was performed in the mitral valve position. Results. The postoperative period was uneventful. Control echocardiography showed a significant improvement in hemodynamic parameters: the average gradient on TC decreased from 6.0-7.2 to 3.1 mmHg, regurgitation decreased from 2 to 0-1 art. On MC, the average gradient decreased from 9.0-10.5 mmHg to 6.7 mmHg, regurgitation was minimal. The patient's condition was satisfactory upon discharge, FC regressed from III-IV to II. Conclusion. Two-stage transcatheter valve implantation using valve-to-valve technology is a highly effective and safe method of treating bioprosthesis dysfunction in high-risk surgical patients, which avoids repeated sternotomy and reduces rehabilitation time.
- 6 June 2026
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 18 (2) , 205-214
Open AccessThe first experience of two-stage transcatheter implantation of bioprostheses in mitral and tricuspid valve (Valve-in-Valve) prostheses in a high-risk surgical patient
Introduction. Structural degeneration of biological prosthetic heart valves is an inevitable complication in the long term, requiring repeated surgery. Repeated open surgery is associated with a high risk in comorbid patients. Valve-in-Valve (ViV) transcatheter technology has become a minimally invasive alternative. Objective. To demonstrate the effectiveness and safety of a two-stage ViV strategy on tricuspid and mitral valves. Material and methods. A clinical case of a patient born in 1947 with mitral valve (MC) and tricuspid valve (TC) bioprostheses 7 years after the initial open prosthetics is presented. The calculated risk of EuroSCORE II was 21.8%. A two-stage strategy was applied: on 09.29.2025, transcatheter implantation of the MyVal 30.5 mm bioprosthesis was performed in the tricuspid valve position, and on 10.10.2025, MyVal 27.5 mm was performed in the mitral valve position. Results. The postoperative period was uneventful. Control echocardiography showed a significant improvement in hemodynamic parameters: the average gradient on TC decreased from 6.0-7.2 to 3.1 mmHg, regurgitation decreased from 2 to 0-1 art. On MC, the average gradient decreased from 9.0-10.5 mmHg to 6.7 mmHg, regurgitation was minimal. The patient's condition was satisfactory upon discharge, FC regressed from III-IV to II. Conclusion. Two-stage transcatheter valve implantation using valve-to-valve technology is a highly effective and safe method of treating bioprosthesis dysfunction in high-risk surgical patients, which avoids repeated sternotomy and reduces rehabilitation time.
- Open Access
- 2 June 2023
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in EMERGENCY MEDICAL CARE
- Vol. 24 (2) , 54-66
Spontaneous soft tissue hematomas in patients with severe COVID‑19 infection
Спонтанные гематомы мягких тканей у пациентов с тяжелой инфекцией COVID‑19
- 2 June 2023
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in EMERGENCY MEDICAL CARE
- Vol. 24 (2) , 54-66
Open AccessSpontaneous soft tissue hematomas in patients with severe COVID‑19 infection
Спонтанные гематомы мягких тканей у пациентов с тяжелой инфекцией COVID‑19
- Open Access
- 8 September 2022
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (2) , 280-268
Features of Diagnosis and Treatment of Spontaneous Extraorganic Hematomas of the Soft Tissues of the Neck and Chest
The possibilities of computed tomography in the diagnosis of spontaneous hematomas (sh) of the soft tissues of the neck and chest and the features of their treatment are shown. Computed tomography with intravenous bolus contrast enhancement is the main method for diagnosing sh, which allows you to specify its exact localization, distribution, determine the structure and volume of the hematoma, the contrast agent exiting the contours of the vessel, and, taking into account the data obtained and the clinic, determines the tactics of treatment.Stable sh does not require surgical treatment. In the case of a large volume of chest hematoma, compression syndrome, hemothorax, drainage is indicated. Unstable sh dictate the need for angiography and, if necessary, endovascular embolization.
- 8 September 2022
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (2) , 280-268
Open AccessFeatures of Diagnosis and Treatment of Spontaneous Extraorganic Hematomas of the Soft Tissues of the Neck and Chest
The possibilities of computed tomography in the diagnosis of spontaneous hematomas (sh) of the soft tissues of the neck and chest and the features of their treatment are shown. Computed tomography with intravenous bolus contrast enhancement is the main method for diagnosing sh, which allows you to specify its exact localization, distribution, determine the structure and volume of the hematoma, the contrast agent exiting the contours of the vessel, and, taking into account the data obtained and the clinic, determines the tactics of treatment.Stable sh does not require surgical treatment. In the case of a large volume of chest hematoma, compression syndrome, hemothorax, drainage is indicated. Unstable sh dictate the need for angiography and, if necessary, endovascular embolization.
- Open Access
- 4 September 2022
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (2) , 238-248
Course and Outcomes of Acute Coronary Syndrome in the Presence of New Coronavirus Infection COVID-19
We analyzed the clinical condition of patients with COVID-19 of varying severity, changes in instrumental and laboratory parameters, and assessed the impact of the severity of the course of a new coronavirus infection on the outcomes of acute coronary syndrome.AIM OF STUDYTo study the mutual influence of acute coronary syndrome and the new coronavirus infection COVID-19 on the nature of the course and outcomes of the disease.Materia l and methodsIn March 21, 2020 – May 31, 2021, 3 625 patients were treated for COVID-19, including 131 patients with acute coronary syndrome due to COVID-19 disease. All patients underwent a number of studies: computed tomography of the chest, electrocardiography, echocardiography, monitoring of biomarkers of myocardial damage, diagnostic coronary angiography and, if necessary, intracoronary therapeutic intervention.ResultsData on the distribution of patients with COVID-19 according to the presence or absence of ST segment elevation on the electrocardiogram and the degree of lung tissue damage, as well as information on mortality in these groups, are presented. The role of troponin I in the assessment of myocardial ischemia was analyzed. The direct dependence of its level on the volume of lung damage was found. The inverse relationship was shown between the degree of damage to the lung tissue and the indices of oxygen saturation in the blood. A poor prognostic value of low left ventricular ejection fraction in patients with COVID-19 disease has been described.ConclusionsThe development of acute coronary syndrome in the course of COVID-19 significantly worsens the prognosis of the disease, which requires the development of algorithms for providing medical care to patients in this category, as well as maximum vigilance in their treatment.
- 4 September 2022
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (2) , 238-248
Open AccessCourse and Outcomes of Acute Coronary Syndrome in the Presence of New Coronavirus Infection COVID-19
We analyzed the clinical condition of patients with COVID-19 of varying severity, changes in instrumental and laboratory parameters, and assessed the impact of the severity of the course of a new coronavirus infection on the outcomes of acute coronary syndrome.AIM OF STUDYTo study the mutual influence of acute coronary syndrome and the new coronavirus infection COVID-19 on the nature of the course and outcomes of the disease.Materia l and methodsIn March 21, 2020 – May 31, 2021, 3 625 patients were treated for COVID-19, including 131 patients with acute coronary syndrome due to COVID-19 disease. All patients underwent a number of studies: computed tomography of the chest, electrocardiography, echocardiography, monitoring of biomarkers of myocardial damage, diagnostic coronary angiography and, if necessary, intracoronary therapeutic intervention.ResultsData on the distribution of patients with COVID-19 according to the presence or absence of ST segment elevation on the electrocardiogram and the degree of lung tissue damage, as well as information on mortality in these groups, are presented. The role of troponin I in the assessment of myocardial ischemia was analyzed. The direct dependence of its level on the volume of lung damage was found. The inverse relationship was shown between the degree of damage to the lung tissue and the indices of oxygen saturation in the blood. A poor prognostic value of low left ventricular ejection fraction in patients with COVID-19 disease has been described.ConclusionsThe development of acute coronary syndrome in the course of COVID-19 significantly worsens the prognosis of the disease, which requires the development of algorithms for providing medical care to patients in this category, as well as maximum vigilance in their treatment.